Van Der Bom JG - Search Results

1

Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study.

Plug I, Van Der Bom JG, Peters M, Mauser-Bunschoten EP, De Goede-Bolder A, Heijnen L, Smit C, Willemse J, Rosendaal FR. Plug I, et al. Among authors: van der bom jg. J Thromb Haemost. 2006 Mar;4(3):510-6. doi: 10.1111/j.1538-7836.2006.01808.x. J Thromb Haemost. 2006. PMID: 16460432 Free article.

2

Seasonal variation in fibrinogen in the Rotterdam Study.

van der Bom JG, de Maat MP, Bots ML, Hofman A, Kluft C, Grobbee DE. van der Bom JG, et al. Thromb Haemost. 1997 Sep;78(3):1059-62. Thromb Haemost. 1997. PMID: 9308754

3

Fibrinolytic activity in peripheral atherosclerosis in the elderly.

van der Bom JG, Bots ML, Haverkate F, Meyer P, Hofman A, Grobbee DE, Kluft C. van der Bom JG, et al. Thromb Haemost. 1999 Feb;81(2):275-80. Thromb Haemost. 1999. PMID: 10064006

4

Endogenous clotting factor activity and long-term outcome in patients with moderate haemophilia.

Fischer K, van der Bom JG, Mauser-Bunschoten EP, Roosendaal G, Beek FJ, de Kleijn P, Grobbee DE, van den Berg HM. Fischer K, et al. Among authors: van den berg hm, van der bom jg. Thromb Haemost. 2000 Dec;84(6):977-80. Thromb Haemost. 2000. PMID: 11154144

5

Long-term outcome of individualized prophylactic treatment of children with severe haemophilia.

van den Berg HM, Fischer K, Mauser-Bunschoten EP, Beek FJ, Roosendaal G, van der Bom JG, Nieuwenhuis HK. van den Berg HM, et al. Among authors: van der bom jg. Br J Haematol. 2001 Mar;112(3):561-5. doi: 10.1046/j.1365-2141.2001.02580.x. Br J Haematol. 2001. PMID: 11260054 Free article.

6

Purity of factor VIII product and incidence of inhibitors in previously untreated patients with haemophilia A.

Mauser-Bunschoten EP, van der Bom JG, Bongers M, Twijnstra M, Roosendaal G, Fischer K, van den Berg HM. Mauser-Bunschoten EP, et al. Among authors: van den berg hm, van der bom jg. Haemophilia. 2001 Jul;7(4):364-8. doi: 10.1046/j.1365-2516.2001.00513.x. Haemophilia. 2001. PMID: 11442640

7

Changes in treatment strategies for severe haemophilia over the last 3 decades: effects on clotting factor consumption and arthropathy.

Fischer K, van der Bom JG, Mauser-Bunschoten EP, Roosendaal G, Prejs R, Grobbee DE, van den Berg HM. Fischer K, et al. Among authors: van den berg hm, van der bom jg. Haemophilia. 2001 Sep;7(5):446-52. doi: 10.1046/j.1365-2516.2001.00545.x. Haemophilia. 2001. PMID: 11554930

8

Discontinuation of prophylactic therapy in severe haemophilia: incidence and effects on outcome.

Fischer K, Van Der Bom JG, Prejs R, Mauser-Bunschoten EP, Roosendaal G, Grobbee DE, Van Den Berg HM. Fischer K, et al. Among authors: van den berg hm, van der bom jg. Haemophilia. 2001 Nov;7(6):544-50. doi: 10.1046/j.1365-2516.2001.00560.x. Haemophilia. 2001. PMID: 11851751

9

Effects of prophylactic treatment regimens in children with severe haemophilia: a comparison of different strategies.

van den Berg HM, Fischer K, van der Bom JG, Roosendaal G, Mauser-Bunschoten EP. van den Berg HM, et al. Among authors: van der bom jg. Haemophilia. 2002 Mar;8 Suppl 2:43-6. doi: 10.1046/j.1351-8216.2001.00120.x. Haemophilia. 2002. PMID: 11966853

10

Prophylactic versus on-demand treatment strategies for severe haemophilia: a comparison of costs and long-term outcome.

Fischer K, van der Bom JG, Molho P, Negrier C, Mauser-Bunschoten EP, Roosendaal G, De Kleijn P, Grobbee DE, van den Berg HM. Fischer K, et al. Among authors: van den berg hm, van der bom jg. Haemophilia. 2002 Nov;8(6):745-52. doi: 10.1046/j.1365-2516.2002.00695.x. Haemophilia. 2002. PMID: 12410642

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

322 results

Search Page

Filters